- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
BioLife Solutions is a medical instruments & supplies business based in the US. BioLife Solutions shares (BLFS) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $26.50 – an increase of 6.08% over the previous week. BioLife Solutions employs 409 staff and has a trailing 12-month revenue of around $147 million.
What's in this guide?
- BLFS shares summary
- Compare share dealing platforms
- Is BLFS stock a buy or sell?
- Stock performance over time
- Can I short BLFS shares?
- Are BLFS shares over-valued?
- BioLife Solutions's financials
- How volatile are BLFS shares?
- Does BioLife Solutions pay a dividend?
- Have BLFS shares ever split?
- Other common questions
Our top picks for where to buy BioLife Solutions stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy BioLife Solutions stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BLFS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy BioLife Solutions stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
BioLife Solutions stock price (NASDAQ: BLFS)
Use our graph to track the performance of BLFS stocks over time.BioLife Solutions shares at a glance
Information last updated 2024-12-19.
| Latest market close | $26.50 |
|---|---|
| 52-week range | $14.50 - $28.88 |
| 50-day moving average | $24.68 |
| 200-day moving average | $22.04 |
| Wall St. target price | $30.20 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.11 |
Is it a good time to buy BioLife Solutions stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
BioLife Solutions price performance over time
Historical closes compared with the close of $27.39 from 2024-12-20
| 1 week (2024-12-18) | 9.65% |
|---|---|
| 1 month (2024-11-25) | 2.32% |
| 3 months (2024-09-25) | 14.22% |
| 6 months (2024-06-25) | 28.23% |
| 1 year (2023-12-22) | 70.87% |
|---|---|
| 2 years (2022-12-23) | 55.10% |
| 3 years (2021-12-23) | 40.86 |
| 5 years (2019-12-24) | 64.50% |
Is BioLife Solutions stock undervalued or overvalued?
Valuing BioLife Solutions stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of BioLife Solutions's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
BioLife Solutions's PEG ratio
BioLife Solutions's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 65.3833. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into BioLife Solutions's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
BioLife Solutions financials
| Revenue TTM | $147 million |
|---|---|
| Gross profit TTM | $54.1 million |
| Return on assets TTM | -5.97% |
| Return on equity TTM | -15.04% |
| Profit margin | -31.32% |
| Book value | $7.04 |
| Market Capitalization | $1.2 billion |
TTM: trailing 12 months
BioLife Solutions share dividends
We're not expecting BioLife Solutions to pay a dividend over the next 12 months.
Have BioLife Solutions's shares ever split?
BioLife Solutions's shares were split on a 1:14 basis on 28 January 2014 . So if you had owned 14 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BioLife Solutions shares – just the quantity. However, indirectly, the new 1300% higher share price could have impacted the market appetite for BioLife Solutions shares which in turn could have impacted BioLife Solutions's share price.
BioLife Solutions share price volatility
Over the last 12 months, BioLife Solutions's shares have ranged in value from as little as $14.5 up to $28.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioLife Solutions's is 1.883. This would suggest that BioLife Solutions's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
BioLife Solutions overview
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Frequently asked questions
What percentage of BioLife Solutions is owned by insiders or institutions?Currently 1.942% of BioLife Solutions shares are held by insiders and 99.744% by institutions. How many people work for BioLife Solutions?
Latest data suggests 409 work at BioLife Solutions. When does the fiscal year end for BioLife Solutions?
BioLife Solutions's fiscal year ends in December. Where is BioLife Solutions based?
BioLife Solutions's address is: 3303 Monte Villa Parkway, Bothell, WA, United States, 98021 What is BioLife Solutions's ISIN number?
BioLife Solutions's international securities identification number is: US09062W2044 What is BioLife Solutions's CUSIP number?
BioLife Solutions's Committee on Uniform Securities Identification Procedures number is: 229049101
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question